Our study showed that CAB39 was upregulated after DCA treatment, and CAB39 inhibition was associated with tumour cell resistance to L-OHP, suggesting that CAB39 plays an important role in regulating the chemoresistance of CRC. The gene discussed is CAB39; the disease is colorectal carcinoma.